Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeted Knockdown of Tim3 by Short Hairpin Rnas Improves the Function of Anti-Mesothelin Car T Cells Publisher Pubmed



Jafarzadeh L1 ; Masoumi E2 ; Mirzaei HR1 ; Alishah K3 ; Fallahmehrjardi K1 ; Khakpoorkoosheh M1 ; Rostamian H1 ; Noorbakhsh F1 ; Hadjati J1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immunology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
  3. 3. Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran

Source: Molecular Immunology Published:2021


Abstract

T-cell immunoglobulin mucin 3 (Tim3) is an immune checkpoint receptor that plays a central role in chimeric antigen receptor (CAR) T cell exhaustion within the tumor microenvironment. This study was aimed to evaluate the effects of targeted-knockdown of Tim3 on the antitumor function of anti-mesothelin (MSLN)-CAR T cells. To knockdown Tim3 expression, three different shRNA sequences specific to different segments of the human Tim3 gene were designed and co-inserted with an anti-MSLN-CAR transgene into lentiviral vectors. To investigate the efficacy of Tim3 targeting in T cells, expression of Tim3 was assessed before and after antigen stimulation. Afterwards, cytotoxic effects, proliferative response and cytokine production of MSLN-CAR T cells and Tim3-targeted MSLN-CAR T cells were analyzed. Our results showed that activation of T cells and MSLN-CAR T cells led to up-regulation of Tim3. Tim3 knockdown significantly decreased its expression in different groups of MSLN-CAR T cells. Tim3 knockdown significantly improved cytotoxic function, cytokine production and proliferation capacity of MSLN-CAR T cells. Our findings indicate that targeted knockdown of Tim3 allows tumor-infiltrating CAR T cells that would otherwise be inactivated to continue to expand and carry out effector functions, thereby altering the tumor microenvironment from immunosuppressive to immunosupportive via mitigated Tim3 signaling. © 2021
Other Related Docs
11. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
12. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
15. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
21. Tumor Immunology, Clinical Immunology (2022)
34. Car T Cells: Living Hiv Drugs, Reviews in Medical Virology (2020)